143 related articles for article (PubMed ID: 34626767)
1. Identification and functional characterization of miR-451a as a novel plasma-based biomarker for occult hepatitis B virus infection.
Hao Q; Wang Q; Qian H; Jiang J; Liu X; Xia W
Microb Pathog; 2021 Dec; 161(Pt A):105233. PubMed ID: 34626767
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of interferon signaling-related microRNAs in occult hepatitis B virus infection.
Wang Y; Zhu P; Qiu J; Wang J; Zhu H; Zhu Y; Zhang L; Zhu J; Liu X; Dong C
Clin Epigenetics; 2017; 9():101. PubMed ID: 28932321
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection.
Chen Y; Li L; Zhou Z; Wang N; Zhang CY; Zen K
Med Microbiol Immunol; 2012 Aug; 201(3):389-95. PubMed ID: 22392036
[TBL] [Abstract][Full Text] [Related]
4. Circulating miRNA expression profile and bioinformatics analysis in patients with occult hepatitis B virus infection.
Hao QQ; Wang QH; Xia W; Qian HZ
J Med Virol; 2020 Feb; 92(2):191-200. PubMed ID: 31513283
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus-Encoded MicroRNA Controls Viral Replication.
Yang X; Li H; Sun H; Fan H; Hu Y; Liu M; Li X; Tang H
J Virol; 2017 May; 91(10):. PubMed ID: 28148795
[TBL] [Abstract][Full Text] [Related]
6. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.
Brunetto MR; Cavallone D; Oliveri F; Moriconi F; Colombatto P; Coco B; Ciccorossi P; Rastelli C; Romagnoli V; Cherubini B; Teilum MW; Blondal T; Bonino F
PLoS One; 2014; 9(10):e110782. PubMed ID: 25350115
[TBL] [Abstract][Full Text] [Related]
7. Altered gut microbiota is associated with the formation of occult hepatitis B virus infection.
Liu B; Yang H; Liao Q; Wang M; Huang J; Xu R; Shan Z; Zhong H; Li T; Li C; Fu Y; Rong X
Microbiol Spectr; 2024 Jul; 12(7):e0023924. PubMed ID: 38785430
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection: detection and significance.
Gerlich WH; Bremer C; Saniewski M; Schüttler CG; Wend UC; Willems WR; Glebe D
Dig Dis; 2010; 28(1):116-25. PubMed ID: 20460899
[TBL] [Abstract][Full Text] [Related]
10. T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.
Bes M; Vargas V; Piron M; Casamitjana N; Esteban JI; Vilanova N; Pinacho A; Quer J; Puig L; Guardia J; Sauleda S
J Hepatol; 2012 Apr; 56(4):765-74. PubMed ID: 22173156
[TBL] [Abstract][Full Text] [Related]
11. Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.
Muto J; Sugiyama M; Shirabe K; Mukaide M; Kirikae-Muto I; Ikegami T; Yoshizumi T; Yamashita YI; Maehara Y; Mizokami M
Ann Hepatol; 2018 July - August ,; 17(4):596-603. PubMed ID: 29893701
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs in hepatitis B virus-infected patients.
Ji F; Yang B; Peng X; Ding H; You H; Tien P
J Viral Hepat; 2011 Jul; 18(7):e242-51. PubMed ID: 21692939
[TBL] [Abstract][Full Text] [Related]
13. Plasma MicroRNA Levels Are Associated With Hepatitis B e Antigen Status and Treatment Response in Chronic Hepatitis B Patients.
van der Ree MH; Jansen L; Kruize Z; van Nuenen AC; van Dort KA; Takkenberg RB; Reesink HW; Kootstra NA
J Infect Dis; 2017 May; 215(9):1421-1429. PubMed ID: 28368488
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
15. The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen.
Ninomiya M; Kondo Y; Kimura O; Funayama R; Nagashima T; Kogure T; Morosawa T; Tanaka Y; Nakayama K; Shimosegawa T
J Viral Hepat; 2016 May; 23(5):330-9. PubMed ID: 26924666
[TBL] [Abstract][Full Text] [Related]
16. Management of occult hepatitis B virus infection: an update for the clinician.
Lledó JL; Fernández C; Gutiérrez ML; Ocaña S
World J Gastroenterol; 2011 Mar; 17(12):1563-8. PubMed ID: 21472122
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
[TBL] [Abstract][Full Text] [Related]
18. Identification of mutations in the S gene of hepatitis B virus in HIV positive Mexican patients with occult hepatitis B virus infection.
Enriquez-Navarro K; Maldonado-Rodriguez A; Rojas-Montes O; Torres-Ibarra R; Bucio-Ortiz L; De la Cruz MA; Torres-Flores J; Xoconostle-Cazares B; Lira R
Ann Hepatol; 2020; 19(5):507-515. PubMed ID: 32592870
[TBL] [Abstract][Full Text] [Related]
19. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
